Board Member
Trulieve Cannabis Corp. (TRLV)Equibles does not estimate personal net worth.
Get an email with a short summary when Trulieve Cannabis Corp. publishes a filing, an earnings call transcript or a press release.
Get TRLV alertsKim Rivers is recorded as Board Member at Trulieve Cannabis Corp. (TRLV) since January 1, 2015 and CEO at Trulieve Cannabis Corp. (TRLV). The newest filing on record that lists Kim Rivers as CEO and Board Member at Trulieve Cannabis Corp. (TRLV) is dated April 29, 2026. Trulieve Cannabis Corp. reported in an 8-K filed June 13, 2025 that Kim Rivers was appointed director, effective June 12, 2025. Trulieve Cannabis Corp. reported in an 8-K filed June 20, 2023 that Kim Rivers was appointed director, effective June 14, 2023. The proxy statement of Trulieve Cannabis Corp. reports total compensation of $7,588,408 for Kim Rivers in fiscal 2025, including a base salary of $850,000. Disclosed compensation is on record for 7 fiscal years. Kim Rivers has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Trulieve Cannabis Corp. on August 7, 2026. Trulieve Cannabis Corp. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Trulieve Cannabis Corp. includes Jan Reese (CFO and Chief Accounting Officer), Ryan Blust (CFO), Timothy Mullany (CFO) and 7 others.
“The shareholders voted to elect the following individuals as directors of the Company until the next annual meeting of shareholders at which election of directors is considered, or until his or her successor is duly elected or appointed:”
“The shareholders voted to elect the following individuals as directors of the Company until the next annual meeting of shareholders at which election of directors is considered, or until his or her successor is duly elected or appointed:”
“We are thrilled to report second quarter results for the first time as a company listed on the New York Stock Exchange.”
“I would now like to call this meeting to order. Pursuant to the corporation's articles, as chair of the board of directors of the corporation, I will preside as chair of the meeting.”
2015-01-01–present
Last confirmed April 29, 2026
Start not stated–present
Last confirmed April 29, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2015-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $850,000 | $7,588,408 |
| 2024 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $850,000 | $5,143,273 |
| 2023 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $750,000 | $3,357,213 |
| 2022 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $500,000 | $3,904,952 |
| 2021 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $500,000 | $8,054,480 |
| 2020 | Trulieve Cannabis Corp. (TRLV) | Chief Executive Officer | $323,958 | $1,040,226 |
| 2019 | Trulieve Cannabis Corp. (TRLV) | President and Chief Executive Officer | $290,845 | $443,750 |
